Meet Dr. Paul M. Friedman: Houston’s Leading Laser Dermatologist
Dr. Paul M. Friedman stands as one of Houston’s most distinguished dermatologists, bringing over 25 years of specialized expertise in laser medicine and dermatologic surgery to patients throughout the greater Houston area. As a board-certified dermatologist and the founder and director of the Dermatology & Laser Surgery Center, Dr. Friedman has established himself as a pioneering force in advanced dermatological treatments, combining cutting-edge technology with compassionate patient care.
About Dr. Paul M. Friedman
Dr. Paul M. Friedman’s journey in dermatology began with his medical degree from the University of Tennessee Health Science Center College of Medicine in Memphis. He then completed his dermatology residency at the prestigious New York University School of Medicine, where he served as chief resident during his final year. Following his residency, Dr. Friedman pursued advanced fellowship training in dermatologic laser surgery, Mohs micrographic surgery, and cutaneous oncology at the renowned Laser & Skin Surgery Center of New York.
This comprehensive training foundation has enabled Dr. Friedman to become a true authority in laser dermatology, with expertise spanning medical dermatology, surgical dermatology, and cosmetic dermatology. His practice serves patients from across Houston, including the Medical Center, River Oaks, Memorial, The Woodlands, and surrounding communities.
25+
years of dermatological practice experience
150+
peer-reviewed publications in leading medical journals
Past President of the American Society for Laser Medicine and Surgery (ASLMS)
Educational Excellence and Training
Dr. Friedman’s educational credentials reflect his commitment to excellence in dermatological care:
Medical Education
- Medical Degree: University of Tennessee Health Science Center College of Medicine, Memphis
- Dermatology Residency:New York University School of Medicine (Chief Resident)
- Fellowship Training:
- Laser & Skin Surgery Center of New York
- Dermatologic Laser Surgery
- Mohs Micrographic Surgery & Dermatologic Oncology
Board Certifications & Credentials
- American Board of Dermatology – Board Certified
- Fellowship Trained in Laser Surgery and Mohs Micrographic Surgery
- Active Medical License: Texas State Medical Board + New York State Medical License
Research Excellence and Publications
With over 150 peer-reviewed publications in leading medical journals, Dr. Friedman has made substantial contributions to dermatological research. His work represents one of the most comprehensive bodies of research in laser dermatology, spanning over two decades of clinical investigation and innovation.
Dr. Paul M. Friedman’s Research Publications by Category
Foundational Laser Research:
Friedman PM, Skover G, Payonk G, Kauvar ANB, Geronemus RG. 3D In-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg. 2002 Mar;28(3):199-204.
Friedman PM, Skover G, Payonk G, Geronemus RG. Quantitative evaluation of non-ablative laser technology. Semin Cutan Med Surg. 2002 Dec;21(4):266-73.
Fractional Resurfacing Cutaneous Applications:
Behroozan DS, Goldberg LH, Glaich AS, Dai T, Friedman PM. Fractional photothermolysis for treatment of poikiloderma of civatte. Dermatol Surg. 2006 Feb;32(2):298-301.
Behroozan DS, Goldberg LH, Dai T, Geronemus RG, Friedman PM. Fractional photothermolysis for the treatment of surgical scars: A case report. J Cosmet Laser Ther. 2006 Apr;8(1):35-8.
Glaich AS, Rahman Z, Goldberg LH, Friedman PM. Fractional photothermolysis for the treatment of hypopigmented scars: A pilot study. Dermatol Surg. 2007 Mar;33:289-94.
Glaich AS, Goldberg LH, Dai T, Friedman PM. Fractional photothermolysis for the treatment of telangiectatic matting: A case report. J Cosmet Laser Ther. 2007 Jun;9(2):101-3.
Glaich AS, Goldberg LH, Dai T, Kunishige JH, Friedman PM. Fractional resurfacing: A new therapeutic modality for Becker’s nevus. Arch Dermatol. 2007 Dec;143(12):1488-1490.
Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars. Dermatol Surg. 2008 Oct;34(10):1327-32.
Kunishige JH, Goldberg LH, Friedman PM. Fractional photothermolysis for the treatment of surgical scars. Dermatol Surg. 2010 Apr;36(4):538-41.
Katz TM, Goldberg LH, Friedman PM. Non-ablative fractional photothermolysis for the treatment of striae rubra. Dermatol Surg. 2009 Sept;35(9):1430-3.
Katz TM, Goldberg LH, Friedman PM. Fractional photothermolysis: A new therapeutic modality for xanthelasma. Arch Dermatol. 2009 Oct;145(10):1091-4.
Katz TM, Goldberg LH, Firoz BF, Friedman PM. Fractional photothermolysis for the treatment of post-inflammatory hyperpigmentation. Dermatol Surg. 2009 Nov;35(11):1844-48.
Katz TM, Goldberg LH, Friedman PM. Dermatosis papulosa nigra treatment with fractional photothermolysis. Dermatol Surg. 2009 Nov;35(11):1840-43.
Katz TM, Goldberg LH, Firoz BF, Friedman PM. The treatment of Darier’s disease using a 1,550-nm erbium-doped fractionated laser. Dermatol Surg. 2010 Jan;36(1):142-51.
Recent Fractional Resurfacing Laser Advances:
Friedman PM, Polder KD, Sodha P, Geronemus RG. The 1440 nm and 1927 nm Nonablative Fractional Diode Laser: Current Trends and Future Directions. J Drugs Dermatol. 2020 Aug 1;19(8):s3-11.
Friedman PM, Dover JS, Chapas A, Rahman Z, Ross EV, Kilmer SL, Roberts W, Waibel JS. Optimizing Outcomes with The 1550/1927 nm Dual Wavelength Non-Ablative Fractional Laser: Experienced User Recommendations. J Drugs Dermatol. 2021 Nov;20(11):1150-1157.
Friedman PM, Dover JS, Chapas A, Rahman Z, Ross EV, Kilmer SL, Roberts WE, Sodha P, Stimmel JB, Moncrief MBC, Waibel JS. 1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations. Dermatol Surg. 2022 Feb 1;48(2):195-200.
Kubicki SL, Guo EL, Sodha P, Richmond H, Friedman PM. Combination 1550 nm non-ablative fractional resurfacing and laser hair removal for treatment of Becker’s nevi in skin types III-VI. Lasers Surg Med. 2023 Jan;55(1):99-104.
Friedman PM, Dover JS, Chapas A, Jacobson A. Current Trends and Future Directions of the Dual 1550-nm Erbium Glass Fiber and 1927-nm Thulium Fiber Non-Ablative Fractional Laser System. Lasers Surg Med. 2025 Sept;57(7):561-570.
Polder KD, Friedman PM, Feetham J, Gower J, Lin T, Jacobson A. Nonablative Fractional Diode Laser Resurfacing (1440 nm and 1927 nm) for Photoaged Skin. Dermatol Surg. 2025 Jan 1;51(1):52-57.
Acne Treatment Research:
Friedman PM, Jih MJ, Kimyai-Asadi A, and Goldberg LH. Treatment of Inflammatory Facial Acne Vulgaris With the 1,450-nm Diode Laser: A Pilot Study. Dermatol Surg. 2004 Feb;30(2):147-151.
Glaich A, Friedman PM, Jih M, Goldberg LH. Treatment of Inflammatory Facial Acne Vulgaris with Combination 595-nm Pulsed Dye Laser with Dynamic-Cooling-Device and 1,450-nm Diode Laser. Lasers in Surgery and Medicine. 2006 Mar;38:177-180.
Jih, MH, Friedman, PM, Goldberg, LH, Robles, M, Glaich, AS, Kimyai-Asadi, A. The 1,450-nm diode laser for facial inflammatory acne vulgaris: Dose-response and 12-month follow-up study. J Amer Acad Dermatol. 2006 Jul;55(1):80-7.
Friedman PM, Jih MH, Skover GR, Payonk G, Kimyai-Asadi A, Geronemus RG. Treatment of atrophic facial acne scars with the 1064-nm q-switched Nd:YAG laser: Six-month follow-up study. Arch Dermatol. 2004 Nov;140:1337-1341.
Glaich AS, Goldberg LH, Friedman RH, Friedman PM. Fractional photothermolysis for the treatment of postinflammatory erythema resulting from acne vulgaris. Dermatol Surg. 2007 Jul;33:1-5.
Chrastil B, Friedman PM. Treatment of atrophic acne scars. Touch Briefings: US Dermatology Review. 2006 Dec;Issue II.
Vascular Laser Technology:
Kauvar ANB, Frew KE, Friedman PM, Geronemus RG. Cooling gel improves pulsed KTP laser treatment of facial telangiectasia. Lasers Surg Med. 2002;30(2):149-53.
Kunishige JH, Goldberg LH, Friedman PM. Laser therapy for leg veins. Clinics in Dermatology. 2007 Sep-Oct;25(5):454-61.
Vergilis-Kalner IJ, Friedman PM, Goldberg LH. Long-pulsed 595-nm pulsed dye laser for the treatment of a glomus tumor. Dermatol Surg. 2010 Sep;36(9):1465-5.
Port-Wine Stain Treatment:
Sodha P, Richmond H, Friedman PM. Safe and Effective Use of a Novel Large Spot Size 595-nm Pulsed Dye Laser With High Energies for Rapid Improvement of Adult and Pediatric Port-Wine Birthmarks. Dermatol Surg. 2021 Aug 1;47(8):1147-1149.
Sodha P, Wang JV, Aboul-Fettouh N, Martin K, Geronemus RG, Friedman PM. Largest Comparative analysis: Novel large spot size 595 nm, high-energy, pulsed dye laser reduces number of treatments of improvement of adult and pediatric port wine birthmarks. Lasers Surg Med. 2023 Oct;55(8):741-747.
Rosacea Treatment:
Suggs AK, Macri A, Richmond H, Munavalli G, Friedman PM. Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study. Lasers Surg Med. 2020 Jan;52(1):38-43.
Sodha P, Suggs A, Munavalli GS, Friedman PM. A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea. Lasers Surg Med. 2021 Dec;53(10):1307-1315.
Advanced Vascular Applications:
Friedman PM, Tolkachjov SN, Geddes ER, Tillman KA, Zachary CB. TRASER: An innovative device for the treatment of nasal telangiectasias. Lasers Surg Med. 2017 Aug;49(6):625-631.
Geddes-Bruce ER, Hamill SS, Zachary CB, Friedman PM. One-year follow up of a TRASER clinical trial for the treatment of nasal telangiectasias. Lasers Surg Med. 2018 Jan;50(1):61-63.
Melasma Treatment Research:
Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM. Treatment of melasma with fractional photothermolysis: a report of eight cases with long term follow-up. Dermatol Surg. 2010 Aug;36(8):1273-80.
Geddes E, Stout AB, Friedman PM. Long-pulsed dye laser of 595-nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. Dermatol Surg. 2016 Apr;42(4):556-9.
Geddes E, Stout AB, Friedman PM. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1,927-nm fractional low-powered diode laser. Lasers in Surgery and Medicine. 2017 Jan;49(1):20-26.
Suggs AK, Hamill SS, Friedman PM. Melasma: update on management. Semin Cutan Med Surg. 2018 Dec;37(4):217-225.
Moody M, Landau JM, Goldberg LH, Friedman PM. Fractionated 1,550-nm Erbium-Doped Fiber Laser for the Treatment of Periorbital Hyperpigmentation. Dermatol Surg. 2012 Jan;38(1):139-42.
Nevus of Ota Treatment:
Landau JM, Vergilis-Kalner I, Goldberg LH, Friedman PM. Treatment of Nevus of Ota in Fitzpatrick Skin Type VI with the 1,064-nm QS Nd:YAG Laser. Lasers Surg Med. 2011 Feb;43(2):65-67.
Moody MN, Landau JM, Vergilis-Kalner I, Goldberg LH, Marquez D, Friedman PM. 1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser and 1,550-nm Fractionated Erbium-Doped Fiber Laser for the Treatment of Nevus of Ota in Fitzpatrick Skin Type IV. Dermatol Surg. 2011 Aug;37(8):1163-7.
Kubicki SL, Guo EL, Richmond H, Friedman PM. Treatment of Nevus of Ota in Black patients with the 1064 nm QS or picosecond laser and nonablative fractional photothermolysis. Lasers Surg Med. 2023 Jan;55(1):67-72.
Swali RN, Estupiñan B, Guo EL, Richmond H, Friedman PM. Efficacy of 785-nm Picosecond Titanium Sapphire Laser for Treatment of Brown Nevus of Ota Lesions in FST II-V: A Retrospective Analysis. Dermatol Surg. 2024 Nov 1;50(11):1046-1049.
Café-au-Lait Macules:
Balaraman B, Ravanfar-Jordan P, Friedman PM. Novel Use of Non-ablative Fractional Photothermolysis for Café-Au-Lait Macules in Darker Skin Types. Lasers in Surgery and Medicine. 2017 Jan;49(1):84-87.
Fernandez JK, Guo EL, Richmond H, Friedman PM. The 730 nm picosecond titanium sapphire laser for treatment of café-au-lait macules in all skin types. Lasers Surg Med. 2024 Mar;56(3):257-262.
Advanced Pigment Treatment:
Swali RN, Susruthi R, Friedman PM. Treatment of Hemosiderin Staining With a 785-nm Picosecond Titanium Sapphire Laser in Combination With a Nonablative 1550-nm Fractional Resurfacing Laser. Dermatol Surg. 2025 Jan 1;51(1):108-109.
Mohs Surgery Research:
Jih MH, Friedman PM, Kimyai-Asadi A, Goldberg LH. Curretage prior to Mohs micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study. Dermatol Surg. 2005 Jan;31(1):10-5.
Jih MH, Friedman PM, Goldberg LH, Kimyai-Asadi A. Surgical Pearl: The use of Polaroid photography for mapping Mohs micrographic surgery sections. J Am Acad Dermatol. 2005 Mar;52(3 Pt1):511-3.
Kimyai-Asadi A, Goldberg LH, Nemeth A, Friedman PM, Jih MH. Mohs micrographic surgery for elliptical excision of skin tumors: a surgical and histologic study. Dermatol Surg. 2004 Oct;30(10):1310-7; discussion 1317-8.
Skin Cancer Treatment:
Friedman PM, Golomb CA, Kirsner RS. Self-Assessment examination. Cutaneous Angiosarcoma. J Am Acad of Dermatol. 1997;36:142-144 and 147-148.
Friedman PM, Friedman RH, Jiang SB, Nouri KN, Amonette RA, Robins P. Microcystic adnexal carcinoma: Collaborative series review and update. J Am Acad Dermatol. 1999 Aug;41(2 Pt 1):225-231.
Silapunt S, Peterson SR, Goldberg LH, Friedman PM, Alam M. Basal cell carcinoma on the vermilion lip: a study of 18 cases. J Am Acad Dermatol. 2004 Mar;50(3):384-7.
Goldberg LH, Silapunt S, Beyrau KK, Peterson SR, Friedman PM, Alam M. Keratoacanthoma as a post-operative complication of skin cancer excision. J Am Acad Dermatol. 2004 May;50(5):753-8.
Silapunt S, Goldberg LH, Friedman PM, Thurber M. Basal cell carcinoma arising on port-wine stain. Dermatol Surg. 2004 Sep;30(9):1241-5.
Topical Anesthesia Research:
Friedman PM, Fogelman JP, Nouri K, Levine VJ, Ashinoff R. Comparative study of the efficacy of four topical anesthetics. Dermatol Surg. 1999 Dec;25(12):950-954.
Friedman PM, Mafong EA, Friedman ES, Geronemus RG. Topical anesthetics update: EMLA and beyond. Dermatol Surg. 2001 Dec;27(12):1019-1026.
Alexiades-Armenakas M, Chen J, Friedman PM, Geronemus RG. Two randomized, double-blind, placebo-controlled studies evaluating S-Caine Peel for induction of local anesthesia prior to long-pulsed Nd:YAG laser therapy for leg veins. Dermatol Surg. 2003 Oct;29(10):1012-1018.
Doshi SN, Friedman PM, Marquez DK, Goldberg LH. Thirty-Minute Application of S-Caine Peel Prior to Non-ablative Laser Treatment. Dermatol Surg. 2003 Oct;29(10):1008-11.
Jih MH, Friedman PM, Sadick N, Marquez DK, Asadi AK, Goldberg LH. 60-minute application of S-caine peel prior to 1,064-nm long-pulsed Nd:YAG laser treatment of leg veins. Lasers Surg Med. 2004;34(5):446-50.
Pain Management Innovations:
Katz TM, Polder TM, Bruce S, Friedman PM. Forced cold air cooling for pain reduction during filler and botulinum toxin injections. Dermatol Surg. 2010 May;36(1):729-828.
Injectable Safety Research:
Friedman PM, Mafong EA, Kauvar ANB, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002 Jun;28(6):491-4.
Mamelak AJ, Graves JJ, Kaye VN, Goldberg LH, Friedman PM. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology. Dermatol Surg. 2009 Oct;35(2):1701-3.
Camacho-Hubbard I, Dick MK, Guo EL, Richmond H, Friedman PM. Clinical Presentations and Complications of Illicit and Large Volume Silicone Injections Performed in Medical Spa Facilities. Dermatol Surg. 2025 Aug 15. Online ahead of print.
Dick MK, Raef H, Richmond H, Guo EL, Friedman PM. Xanthelasma Palpebrarum Associated With Use of Hyaluronidase. Dermatol Surg. 2025 Oct 17. Online ahead of print.
Body Contouring Research:
Singh S, Geddes E, Boutros S, Galindo Robert, Friedman PM. Paradoxical Adipose Hyperplasia Secondary to Cryolipolysis: An Underreported Entity. Lasers in Surgery and Medicine. 2015 May;47:476-478.
Ward CE, Li JY, Friedman PM. ATX-101 (Deoxycholic Acid Injection) for Paradoxical Adipose Hyperplasia Secondary to Cryolipolysis. Dermatol Surg. 2017 Oct.
Pinney SS, Geddes ER, Friedman PM, Jogi M. Effects of cryolipolysis on testosterone. Dermatol Surg. 2017 March.
Laser-Enhanced Drug Delivery:
Wang JV, Friedman PM, Agron S, Konda A, Parker C, Geronemus RG. Quantifying Skin Uptake of Topicals After 1,927-nm and 1,440-nm Nonablative Fractional Diode Laser Treatment. Dermatol Surg. 2022 Aug 1;48(8):822-826.
Wang JV, Friedman PM, Johnson J, Konda A, Keator L, Geronemus RG. Key Parameters of non-ablative fractional laser pretreatments for enhanced topical uptake. J Cosmet Dermatol. 2022 Sep;21(9):3803-3808.
Wang JV, Friedman PM, Rodeberg D, Konda A, Parker C, Geronemus RG. Enhancing Skin Uptake of Topical Antioxidants With 1,440-nm Nonablative Fractional Diode Laser Pretreatment. Dermatol Surg. 2022 Sep 1;48(9):927-931.
Wang JV, Friedman PM, Agron S, Konda A, Parker C, Geronemus RG. Enhanced Uptake and Retention of 0.03% Bimatoprost, 0.5% 5-Fluorouracil, and 5% Minoxidil After 1,550-nm or 1,927-nm Nonablative Laser Pretreatment. Dermatol Surg. 2022 Sep 1;48(9):932-936.
Tattoo Removal Technology:
Vangipuram R, Hamill SS, Friedman PM. Accelerated tattoo removal with acoustic shock wave therapy in conjunction with a picosecond laser. Lasers Surg Med. 2018 Jun 25.
Vangipuram R, Hamill SS, Friedman PM. Perfluorodecalin-infused patch in picosecond and Q-switched laser-assisted tattoo removal: Safety in Fitzpatrick IV-VI skin types. Lasers Surg Med. 2019 Jan;51(1):23-26.
Moustafa F, Suggs A, Hamill SS, Friedman PM. Successful Treatment of Cosmetic Eyebrow Tattoos in Fitzpatrick III-IV With Picosecond (1,064, 532-nm) Neodymium-Doped Yttrium Aluminum Garnet Laser With a Perfluorodecalin-Infused Patch: A Pilot Study. Lasers Surg Med. 2020 Sep;52(7):586-589.
Sodha P, Wang JV, Friedman PM. Acoustic Shockwave Therapy as an Adjunct to Picosecond Laser for Multicolored Tattoo Removal: Procedural Overview. Dermatol Surg. 2022 Jan 1;48(1):153-155.
Swali RN, Guda A, Friedman PM. Yellow Is the New Red: Clearance of a Yellow Microbladed Tattoo With a 532-nm Picosecond Laser. Dermatol Surg. 2025 May. 1;51(5):559-561.
Dick MK, Camacho-Hubbard I, Swali R, Friedman PM. Treatment of Cosmetic Eyeliner Tattoo Blow-Out With 1064-nm Nd:YAG Picosecond Laser. Dermatol Surg. 2025 Mar 20;51(7):739-740.
Social Impact Research:
Guo EL, Kream E, Merlo A, Friedman PM. Liberating more than light: Laser removal of branding tattoos is impactful in the recovery of sex trafficking survivors. Lasers Surg Med. 2023 Jan;55(1):61-66.
Suggs AK, Wang JV, Friedman PM. Experiences With Corrective Laser Tattoo Removal: Dangers of Nonphysician Operators. Dermatol Surg. 2021 Jul 1;47(7):1035-1037.
Pollock S, Ferree S, Cronin M, Judge AM, Berson DS, Friedman PM, Grimes PE, Murase JE, Freeman EE, Rao M, Malik S, Balk R, Miller J, Cronin TA Jr, Kourosh AS. Dermatology’s role in the fight against human trafficking: A report from the AAD Ad Hoc Task Force and call to action. J Am Acad Dermatol. 2024 Feb;90(2):339-341.
Patin E, Mangual KPS, Ashrafzadeh S, Kinariwalla N, Marcelus C, Friedman PM, Kourosh AS. Exportable Model of a Pro-Bono Laser Tattoo Removal Clinic: Guidelines for Clinicians Seeking to Make an Impact in Their Communities. Lasers Surg Med. 2025 Sep 24. Online ahead of print.
Rare Dermatological Conditions:
Friedman PM, Chang WM. Selected pearls from the New York University Clinical Conference. Case report # 1: Incontinentia pigmenti. J Clin Dermatol. 1999;2(2):35-37.
Friedman PM and Rico MJ. Cutaneous endometriosis. Dermatol Online J. 2000 Sep;6(1):8.
Chrastil B, Glaich AS, Goldberg LH, Friedman PM. A novel treatment for disseminated superficial actinic porokeratosis. Arch Dermatol. 2007 Nov;143(11):1450-1452.
Wolfshohl J, Geddes ERC, Stout AB, Friedman PM. Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment. Laser in Surgery and Medicine. 2017 Jan;49(1):60-62.
Complex Case Management:
Jih MH, Friedman, PM, Kimyai-Asadi A., Goldberg LH. A rare case of fatal primary cutaneous mucinous carcinoma of the scalp with multiple in-transit and pulmonary metastases. J Am Acad Dermatol. 2005 May S76-80.
Murray TN, Rajanala S, Friedman PM. Improvement of Lichen Planus Pigmentosus-Like Drug Reaction Using a Combination of the Fractionated 1,550-nm Erbium-Doped Fiber Laser and Topical Cysteamine Cream. Dermatol Surg. 2023 Nov 1;49(11):1046-1048.
Jih MH, Friedman PM, Friedman ES, Hymes SR, Kimyai-Asadi A, Goldberg LH. Lupus miliaris disseminatus faciei: treatment with the 1,450-nm diode laser. Arch Dermatol. 2005 Feb;141(2):143-5.
Innovative Treatment Applications:
Hamill SS, Geddes-Bruce E, Friedman PM. Nonablative Fractional 1,550-nm Laser for the Treatment of an Unusual Nevus Sebaceus. Dermatol Surg. 2019 Dec;45(12):1728-1731.
Singh S, Peterson J, Friedman PM. Management of Mild to Moderate Rhinophyma with Ablative Fractional Photothermolysis. Derm Surg. 2013 Jul;39(7):1110-3.
Practice Standards Research:
Friedman PM, Jih MH, Burns AJ, Geronemus RG, Kimyai-Asadi A, Goldberg LH. Nonphysician practice of dermatologic surgery: the Texas perspective. Dermatol Surg. 2004 Jun;30(6):857-63.
Valiga A, Albornoz CA, Chitsazzadeh V, Wang JV, Saedi N, Geronemus RG, Friedman PM. Medical Spa Facilities and Nonphysician Operators in Aesthetics. Clin Dermatol. 2022 May-Jun;40(3):239-243.
Kubicki SL, Wang JV, Geronemus RG, Friedman PM. Delegation and oversight of non-physician practitioners in dermatology. Clin Dermatol. 2023 Mar-April;41(2):257-261.
Murray TN, Lohray R, Schultz KP, Boutros S, Friedman PM. Complications of Chemical Peels, Lasers, and Energy-Based Device Procedures Performed by Core Cosmetic Physicians: A Retrospective Analysis. Lasers Surg Med. 2024 Sep; 56(7):619-624.
Murray TN, Salame N, Friedman PM. A Retrospective Analysis of Complications of Minimally Invasive Cosmetic Procedures Seen at a Referral Practice in Houston. Dermatol Surg. 2023 Sep. 1;49(9):897-899.
Han S, Swali RN, Guo EL, Friedman PM. Pink Bumps on the Face After Microneedling. Dermatol Surg. 2024 Jul 1;50(7):692-693.
Medical Education:
Patel AD, Guo E, Sodha P, Friedman PM. Laser Education in Dermatology Residency: Outcomes of a Resident-Reported Survey. Dermatol Surg. 2022 Oct 1;48(10):1129-1131.
Novel Laser Technologies:
Murray TN, Guo EL, Richmond H, Friedman PM. Single treatment scar resurfacing with a novel ablative fractional 2910 nm erbium-doped fluoride glass fiber laser. Lasers Surg Med. 2024 Jan;56(1):19-22.
Murray TN, Hu JK, Friedman PM. Full-face and neck resurfacing with a novel ablative fractional 2910 nm erbium-doped fluoride glass fiber laser for advanced photoaging. Lasers Surg Med. 2024 Mar;56(3):249-256.
Murray TN, Maredia H, Friedman PM. Histological analysis of laser-enabled tissue coring with a novel 2910 nm erbium-doped fluoride glass fiber laser. Lasers Surg Med. 2024 Jul;56(5):462-465.
Murray TN, Dick M, Friedman PM. A Novel Ablative Fractional 2,910-nm Erbium-Doped Fluoride Glass Fiber Laser for the Treatment of Photoaging in Fitzpatrick Skin Type IV. Dermatol Surg. 2025 May 1;51(5):572-574.
Swali RN, Murray TN, Eason CD, Friedman PM. Nasal Contouring With an Ablative 2,910-nm Fiber Laser. Dermatol Surg. 2025 Oct;51(10):1008-1010.
Pain Management Innovation:
Murray TN, Darji K, Friedman PM. Split-face study to evaluate efficacy of global cryomodulation for reduction of pain and inflammation after nonablative fractional resurfacing. Laser Surg Med. 2024 Jan;56(1):75-80.
Murray TN, Friedman PM. Split-Face Study to Evaluate the Efficacy of a Novel Global Cryomodulation for Reduction of Pain and Inflammation After Pulsed Dye Laser. Dermatol Surg. 2024 Dec. 1;50(12):1220-1223.
Books:
Avram M, Avram M, Friedman PM. Lasers & Light Source Treatment For The Skin. Jaypee Brothers Medical Publishers LTD, New Delhi, India, March 2014.
Book Chapters:
Friedman PM and Ashinoff R. Hemangiomas, Lymphangiomas. In: Freedberg IM, Sanchez M, Eds. Current Dermatologic Diagnoses and Treatment. Current Medicine, Inc., Philadelphia, PA, 2001.
Friedman PM and Doris DJ. Cryotherapy. In: Freedberg IM, Sanchez M, Eds. Current Dermatologic Diagnoses and Treatment. Current Medicine, Inc., Philadelphia, PA, 2001.
Friedman PM and Geronemus RG. Dermatofibrosarcoma protuberans, Merkel cell carcinoma, Paget’s disease. In: Freedberg IM, Sanchez M, Eds. Current Dermatologic Diagnoses and Treatment. Current Medicine, Inc., Philadelphia, PA, 2001.
Jih MH and Friedman PM. Psoriasis. In: Dover J, Alam M, Goldberg D, Eds. Procedures in Cosmetic Dermatology Series, Lasers and Lights. Elsevier Saunders, Inc. Philadelphia, PA, 2005.
Friedman PM, Mafong EA, Glaich AS, and Geronemus RG. Topical Anesthesia. In: Goldman MP, Weiss RA. Advanced Techniques in Dermatologic Surgery. Taylor & Francis Group, New York, NY, 2006.
Jih MH, Friedman PM, and Kimyai-Asadi A. Psoriasis. In: Dover J, Alam M, Goldberg D, Eds. Procedures in Cosmetic Dermatology Series, Lasers and Lights, Vol I, 2nd Edition. Elsevier Saunders, Inc. Philadelphia, PA, 2009.
Kunishige JH and Friedman PM. Non-ablative Laser and Light Sources. In: Alam M, Gladstone HB, Tung RC, Eds. Requisites in Dermatology: Cosmetic Dermatology. Elsevier Saunders, Inc. Philadelphia, PA, 2009.
Friedman PM and Chrastil BM. Off-face Treatment of Keratoses and Lentigines. In: Alam M, Eds. Body Rejuvenation. Springer Science+Business Media, Inc. New York, NY.
Geddes ER, Ravanfar P, and Friedman PM. Non-ablative Fractional Resurfacing. In: Avram M, Avram M, Friedman PM, Eds. Cosmetic Laser Surgery. Jaypee Brothers Medical Publishers LTD. New Delhi, India, 2014.
Risner-Rumohr S, Ravanfar P, and Friedman PM. Ablative Fractional Resurfacing. In: Avram M, Avram M, Friedman PM, Eds. Cosmetic Laser Surgery. Jaypee Brothers Medical Publishers LTD. New Delhi, India, 2014.
Ward CE, Li JY, Hamill SS, Friedman PM. Chapter 1.2 Melasma. In: Alexiades M Zubek A, editors. Cosmetic Dermatologic Surgery, 1st edition, Philadelphia: Lippincott Williams & Wilkins; 2019. p. 17-38.
Guo El, Wang JV, Geronemus RG, Friedman PM. Combination Treatment Approach to Melasma. In: Branham GH, Dover JS, Khetarpal S, Ramanadham SR, Wulc AE, Eds. Advances in Cosmetic Surgery, Vol 4, Issue 1. Elsevier Saunders, Inc. Philadelphia, PA, 2021.
Sodha P, Friedman PM. Laser Resurfacing. In: Rohrich RJ, Sinno S, Afrooz PN. Masters of Cosmetic Surgery – The Video Atlas: The Dallas Cosmetic Model Thieme. 2021.
Research Impact & Recognition
Dr. Friedman’s research has fundamentally shaped the field of laser dermatology. His work on fractional photothermolysis has been cited thousands of times and has established the safety and efficacy protocols used worldwide. His investigations into laser-enhanced drug delivery represent cutting-edge research that is opening new therapeutic possibilities.
Key Research Achievements:
- Pioneered fractional laser technology applications for multiple dermatological conditions
- Established safety protocols for laser treatments across all skin types
- Advanced understanding of laser-tissue interactions and optimal treatment parameters
- Developed innovative combination therapies for complex dermatological conditions
- Contributed to humanitarian applications of laser technology for trafficking survivors
Awards and Recognition
Dr. Friedman’s contributions to dermatology have earned him numerous prestigious awards:
- Leon Goldman Memorial Award (2019) – The highest honor bestowed by ASLMS
- AAD Presidential Citation (2024) – For leadership in dermatology and human trafficking advocacy
- Presidential Citation Award – American Society for Laser Medicine and Surgery
- Dr. Richard E. Fitzpatrick Best Clinical and Innovations Award (2015) – Abstract awarded by ASLMS
- Best of Cutaneous Applications Award (2016) – Abstract awarded by ASLMS
- Medscape Physician of the Year (2022) – Recognized for philanthropic leadership
- Physician of the Year (2022) – Outstanding achievement in the diagnosis and treatment of children and adults affected by vascular birthmark, anomaly, or associated syndrome by The Vascular Birthmark Foundation
- Texas Top Doctor Recognition and Hall of Fame honoree – 10+ consecutive years by Houston peers and patients
- Castle Connolly Top Doctors – 10+ consecutive years
Leadership in Laser Medicine and Surgery
Dr. Friedman’s influence extends far beyond his Houston practice. He served as President of the American Society for Laser Medicine and Surgery (ASLMS) from 2022-2023, recognizing his significant contributions to advancing laser technology and safety standards in dermatology.
His leadership roles include:
- Past President: American Society for Laser Medicine and Surgery (ASLMS) 2022-2023
- Clinical Professor: University of Texas Medical School, Department of Dermatology
- Clinical Professor: Weill Cornell Medical College, Department of Dermatology
- Fellowship Director: Dermatology & Laser Surgery Center
Specialized Services and Expertise
Dr. Friedman’s practice encompasses the full spectrum of dermatological care, with particular expertise in:
Advanced Laser Treatments
- Fractional laser resurfacing for skin rejuvenation and scar treatment
- Vascular laser therapy for port-wine stains and spider veins
- Pigment-specific lasers for age spots, birthmarks and melasma
- Acne scar revision using multiple laser modalities
- Radiofrequency microneedling to stimulate collagen and smooth fine lines
Cosmetic Dermatology
- Injectable treatments (BOTOX®, dermal fillers)
- Non-surgical facial rejuvenation
- Advanced anti-aging treatments
Academic Appointments and Hospital Affiliations
Dr. Friedman maintains active academic appointments and hospital affiliations:
Academic Positions
- Clinical Professor: University of Texas Medical School, Department of Dermatology
- Clinical Professor: Weill Cornell Medical College, Department of Dermatology
- Fellowship Training Director: Dermatology & Laser Surgery Center
Hospital Affiliations
- Houston Methodist Hospital – Active Staff
- Memorial Hermann-Texas Medical Center – Active Staff
These affiliations ensure Dr. Friedman remains at the forefront of medical advances while contributing to the education of future dermatologists.
Professional Memberships & Certifications
Dr. Friedman maintains active membership in leading professional organizations:
American Academy of Dermatology (AAD) – Fellow
American Society for Dermatologic Surgery (ASDS) – Fellow
American Society for Laser Medicine and Surgery (ASLMS) – Past President
Texas Dermatological Society – Active Member
Harris County Medical Society – Active Member
Safety Protocols & Quality Assurance
Patient safety is paramount at Dr. Friedman’s practice. Our comprehensive safety protocols include:
Safety Measures
- Sterile technique protocols for all procedures
- Advanced laser safety certification for all staff
- Emergency response procedures and equipment
- Infection control measures exceeding industry standards
- Regular equipment calibration and maintenance
Quality Assurance
- Board certification maintenance through continuing education
- Peer review participation in professional organizations
- Patient outcome tracking and quality improvement initiatives
- Staff training and certification programs
Consultation Process & Patient Care
What to Expect During Your Consultation
Dr. Friedman believes in thorough, personalized consultations that typically include:
- Comprehensive skin assessment and medical history review
- Digital imaging and analysis when appropriate
- Detailed treatment plan discussion with realistic expectations
- Risk and benefit analysis for all recommended procedures
- Cost transparency and financing options review
Treatment Risks & Realistic Expectations
All medical procedures carry inherent risks. Dr. Friedman ensures patients understand:
- Realistic timeline for results and recovery
- Alternative treatment options when applicable
- Post-treatment care requirements and follow-up schedule
- Common side effects and their duration
- Rare but serious complications and their management
Philanthropic Initiatives and Community Impact
Beyond his clinical practice, Dr. Friedman is deeply committed to humanitarian causes:
Human Trafficking Advocacy
Dr. Friedman has been instrumental in spearheading the New Beginnings Branding Tattoo Removal program through ASLMS, which provides free laser treatments for survivors of human trafficking, helping to remove branding tattoos and restore dignity to survivors. This groundbreaking work has been recognized nationally and has helped hundreds of survivors begin their healing journey. Dr. Friedman was recognized as one of Medscape’s Physicians of the Year: The Best of 2022 for his philanthropic campaign.
Vascular Birthmark Foundation
Through his work with the Vascular Birthmark Foundation, Dr. Friedman has provided free laser treatments to children with port-wine stains and other vascular birthmarks, improving both their physical appearance and quality of life. Dr. Friedman was awarded Physician of the Year 2022 by The Vascular Birthmarks Foundation for outstanding achievement in the diagnosis and treatment of children and adults affected by vascular birthmark, anomaly, or associated syndrome.
Frequently Asked Questions
How do I know if laser treatment is right for me?
Dr. Friedman conducts comprehensive consultations to evaluate your skin condition, medical history, and aesthetic goals. During this assessment, he’ll determine if you’re a good candidate for laser treatments and discuss all available options.
What makes Dr. Friedman's laser treatments different?
With over 25 years of experience and 150+ published research papers on laser dermatology, Dr. Friedman combines evidence-based medicine with the latest technology. His fellowship training and leadership in American Society Laser Surgery & Medicine ensure you receive the most advanced, safest treatments available.
How long do results typically last?
Results vary depending on the specific treatment and individual factors. During your consultation, Dr. Friedman will provide realistic expectations for your specific condition and treatment plan, including maintenance recommendations.
Are there financing options available?
Yes, we offer convenient financing through CareCredit® and Alphaeon™. A member of our staff can help you learn more about your options.